Mirae Asset Global Investments Co., Ltd. Maxcyte, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Maxcyte, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 4,107 shares of MXCT stock, worth $9,199. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,107
Previous 3,314
23.93%
Holding current value
$9,199
Previous $9,000
11.11%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding MXCT
# of Institutions
118Shares Held
71.6MCall Options Held
0Put Options Held
0-
Cadian Capital Management, LP New York, NY10MShares$22.5 Million1.17% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$18.2 Million0.0% of portfolio
-
Morgan Stanley New York, NY7MShares$15.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.57MShares$12.5 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$11.3 Million13.13% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $228M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...